Professional Documents
Culture Documents
Thalassemia
Heterogenous group of inherited disorders,
characterized by diminished synthesis of
structurally normal globin chains.
Decreased chains thalassemia ;
chains thalassemia
Other uncommon variants: ,, ,
thalassemias
Thalassemia
Traditionally considered as a quantitative
abnormality of hemoglobin synthesis.
However may be a/w mutations resulting
in production of structural variants(Hb
Lepore ,Hb E) or hyperunstable Hb
variants with thalassemic phenotype
(thalassemic hemoglobinopathy)
Both beta and alpha thalassemia may
occur in a/w structural variants
Beta
Heterozygotes
for B thal
alpha
Alpha thal
Beta
Imbalance
Balance
HPFH
Balance
alpha
Imbalance
Unstable
Hb
Hb A tetramer
globin
globin
globin
globin
Thalassemia
First described by Thomas Cooley in 1925.
a.k.a Cooleys anemia, Mediterranean anemia.
Thalassemia molecular
pathogenesis
Mutations
Any step in the pathway of globin chain
expression may be affected
Transcription defects
M-RNA processing defects
Translational defects
Post translational modification of the beta
globin poplypeptide chain
Mutations:
PROMOTER REGION
Point mutation
Prevents RNA polymerase
binding
75% in transcription
+ thal
CHAIN TERMINATOR
Premature termination of mRNA
translation
1) Creation of new stop codon within an
exon
2) Frame shift mutations
Globin not synthesized
0 thal
SPLICING (COMMONEST)
Introns / Exons : 2 types
Ectopic splice junction
In introns
Abnormal splice junctions :
Normal and abn splicing occurs
Unspliced mRNA degraded in nucleus Normal and abn globins
0 thal
produced
+ thal
Thalassemia
-pathogenesis
Chronic hemolysis
Insidious anemia in I yr of life
Hepatosplenomegaly by 3 years
Iron overload with repurcussions on organ systems
Hepatosplenomegaly , prominent cheek bones
(Mongoloid facies), cardiac disease CCF, 2dary
hemochromatosis
Untreated children growth retardation, die of
anemia
Transfusion dependant improves anemia
BMT/gene therapy
Lab diagnosis
Hb : 3-6gm/dl,
RBC count : Normal / increased
RBC Indices :
MCV,MCH,MCHC
PS : RBC :
Marked anisopoikilocytosis, MCHC
Target cells
Basophilic stippling
nRBCs +
Fragmented RBCs
WBC : Slight shift to left,
Platelets : Normal
Reticulocyte count :
URINE
Dark Brown
Hemosiderinuria
Lab diagnosis
BM :
Hypercellular ,
Erythoid : :
Micronormoblast :
Basophilic stippling
chain inclusions in normoblasts
Iron stores
Osmotic Fragility :
Alkali denaturation test
Globin chain synthesis analysis
Beta globin gene analysis
Prenatal diagnosis :
Haptoglobin, Hemopexin :
HPLC/Hb electrophoresis
00
HbA : Nil
HbF : >90%,
HbA2 : N/
+ +
HbA : >50%,
HbA2 : 2.5 %,
HbF : 20-40%
Disorder
HbA
HbA2
HbF
90-95
3.5-7
1-5
10-90
1.5-4
10-90
1.5-4
98
HPFH
60-85
1-2
15-35
PS:
PS:
Thalassemia minor
More common
Heterozygous , protection from falciparum malaria
Asymptomatic
Anemia mild
PS same, lesser degree, BM- mild hyperplasia
Hb A2 (N- 2.5%), Hb F N/ slight
Thalassemia
Reduced or absent synthesis of chains
4 -globin genes (ch 16), severity depends on
no. of genes affected
Children : 4 tetramer forms Hb barts,
Adults : 4 tetramer forms HbH (fast Hb)
Free & chains more soluble than free
chains hence IE is less severe than in thal
Thalassemia
thal trait : / -/- (Asian) or /- /- (African);
III to thal minor,
/ -/- : can result in progeny with HbH or Hydrops
fetalis
Hb H disease : Deletion of 3 globulin genes. Increased 02 affinity hypoxia, prone for oxidation
inclusions by vital stains, III to thal inter.
Hydrops fetalis : Deletion of all 4 globulin genes.
Most severe form, Hb barts having 02 affinity ,
fetus : severe pallor, generalised edema, massive
hepatosplenomegaly
MCV >78 fl
MCH >27pg
MCV <78 fl
MCH <27pg
HbA2 <3%
HbF <1.5%
HbA2 <3.5%
HbF <1.5%
Normal
MCV <78 fl
MCH <27pg
HbA2 > 3.5%
HbF 1-5%
MCV <<78 fl
MCH <<27pg
HbA2 <3%
HbF 5-20%%
DeltaBeta-thal
HPFH
???